Skandinaviska Enskilda Banken (SEB)
PLRX icon

Skandinaviska Enskilda Banken (SEB)’s Pliant Therapeutics PLRX Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-65,582
Closed -$839K – 869
2024
Q4 		$839K Hold
65,582
– – ﹤0.01% 675
2024
Q3 		$736K Hold
65,582
– – ﹤0.01% 696
2024
Q2 		$704K Hold
65,582
– – ﹤0.01% 664
2024
Q1 		$976K Hold
65,582
– – ﹤0.01% 660
2023
Q4 		$1.19M Hold
65,582
– – 0.01% 673
2023
Q3 		$1.14M Hold
65,582
– – 0.01% 659
2023
Q2 		$1.19M Buy
65,582
+35,092
+115% +$831K 0.01% 676
2023
Q1 		$811K Buy
+30,490
New +$868K 0.01% 719

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s PLRX Position: Q1 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Pliant Therapeutics (PLRX) in Q1 2025, closing a stake of 65,582 shares — an estimated $839K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in PLRX in Q1 2023 and held it in 8 quarters. The position peaked at $1.19M in Q2 2023. 140 funds tracked by Wall St. Rank hold PLRX as of Q1 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Pliant Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 65,582 Pliant Therapeutics shares in Q1 2025, an estimated $839K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Pliant Therapeutics in Q1 2023 and held it in 8 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Pliant Therapeutics position peaked at $1.19M in Q2 2023.
  • 140 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2025, filed 7 May 2025.